Teva 2 weeks from closing Ivax deal

Teva agreed to buy Ivax in July for $7.4 billion, the largest ever acquisition by an Israeli company.

teva logo 88 (photo credit:)
teva logo 88
(photo credit: )
Teva Pharmeceutical Industries said Sunday it expects to close its acquisition of Ivax Corporation by January 12. Teva agreed to buy Ivax in July for $7.4 billion, the largest ever acquisition by an Israeli company. The companies said they have signed a consent order for submission to the US Federal Trade Commision (FTC) which is "the last remaining regulatory condition to the consummation of the transaction."